Huvepharma Inc. Sustainability Profile
Huvepharma Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various global regions. Founded in 2001, the company has established itself as a leader in animal health and nutrition, focusing on innovative solutions that enhance livestock productivity and welfare. Specialising in the development of veterinary pharmaceuticals, nutritional products, and feed additives, Huvepharma is recognised for its commitment to quality and efficacy. Its core offerings include antibiotics, probiotics, and enzyme products, which are designed to support animal health and optimise performance. With a strong market position, Huvepharma has achieved significant milestones, including numerous regulatory approvals and partnerships that underscore its reputation for excellence in the industry. The company continues to drive advancements in animal health, making it a trusted name among veterinarians and livestock producers worldwide.
DitchCarbon Score
How does Huvepharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huvepharma Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huvepharma Inc.'s reported carbon emissions
Huvepharma Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported emissions figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organisation. In terms of climate commitments, there are no documented reduction targets or initiatives listed, including those from the Science Based Targets initiative (SBTi) or other climate pledges. This lack of data suggests that Huvepharma Inc. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it is essential for Huvepharma Inc. to establish clear emissions reduction targets and commitments to align with global climate goals.
How Carbon Intensive is Huvepharma Inc.'s Industry?
How Carbon Intensive is Huvepharma Inc.'s Location?
Huvepharma Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Huvepharma Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
